Opsumit 10 MG
Ended Awarded
- Contract number
- 36C24526N0181
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,235
Award facts
- Contract value 100% obligated
- $22,234.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
About this award
Actelion Pharmaceuticals US, Inc. received a delivery order award on December 9, 2025, valued at $22,234.77 for the supply of Opsumit 10 mg, a specialized pharmaceutical product used in the treatment of pulmonary arterial hypertension. This firm fixed-price delivery order, which utilizes no small business set-aside designation, will be performed in Lake Mary, Florida, with an ultimate completion date of December 11, 2025. The contract is funded by the Department of Veterans Affairs through the Veterans Integrated Service Network 5, reflecting the agency's commitment to providing essential medications to eligible veteran populations.
This delivery order is issued under Actelion's Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, a master schedule vehicle that enables streamlined procurement of specialized pharmaceutical products across federal healthcare institutions. As a leading supplier of rare disease medications to the Department of Veterans Affairs and Federal Bureau of Prisons, Actelion maintains multiple indefinite delivery vehicles valued at over $421 million, allowing federal agencies to access critical drug therapies through pre-negotiated pricing mechanisms. The modest contract value reflects a targeted procurement for a specific medication requirement within the established framework of the company's existing federal supply agreements.
Quick answers
Who was awarded contract 36C24526N0181?
36C24526N0181 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 9, 2025.
How much is contract 36C24526N0181 worth?
The government has obligated $22,235 on 36C24526N0181.
Is contract 36C24526N0181 an order under another contract?
Yes. 36C24526N0181 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0181 competed?
The extent of competition for 36C24526N0181 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award